Beijing Tongrentang Co., Ltd (SHSE: 600085)
Health Care · Pharmaceuticals · CN
CN¥24.28
+2.27% today · -29.7% 1Y
Beijing Tongrentang Co., Ltd (SHSE: 600085) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.97B and employs 17,284 people.
Over the last twelve months the share price has lost 29.7%, trading between 21.87 and 35.87.
Tweenvest scores Beijing Tongrentang Co., Ltd across four factors: quality 82/100, value 70/100, growth 34/100, dividend 45/100. Its strongest factor is quality.
600085 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.97B
- Revenue (TTM)
- $2.34B
- P/E
- 34.34
- EPS
- 0.71
- Dividend yield
- 4.12%
- Beta (5Y)
- 0.03
- 52-week high
- CN¥35.87
- 52-week low
- CN¥21.87
- Avg volume (3M)
- —
- Shares outstanding
- 1.37B
- Employees
- 17,284
- Next earnings
- —
About Beijing Tongrentang Co., Ltd
Beijing Tongrentang Co., Ltd engages in the production and sale of traditional Chinese medicine preparations in China and internationally. The company offers various product dosage forms, such as pills, powders, medicated wines, capsules, oral liquids, and drop pills. Its products are used for cardiovascular, cerebrovascular, gynecology, heat-clearing, respiratory system, nourishing and calming, digestive, pediatrics, wind-dispelling and dampness removing, orthopedics, facial features, dermatological surgery, mental health, and food and beverages applications. The company was founded in 1997 and is based in Beijing, China. Beijing Tongrentang Co., Ltd operates as a subsidiary of China Beijing Tong Ren Tang Group Co. Ltd.
- ISIN
- CNE000000R69
- Founded
- 1997
- Listed since
- Jun 27, 1997
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Veradermics, IncorporatedNYSE: MANE | $5.47B | $125.45 | -4.17% |
| Gland Pharma LimitedNSEI: GLAND | $5.22B | Rs3,061.80 | +6.52% |
| Shenzhen Salubris Pharmaceuticals Co., Ltd.SZSE: 002294 | $5.12B | CN¥30.93 | +0.88% |
| Ipca Laboratories LimitedNSEI: IPCALAB | $5.02B | Rs1,915.40 | -1.43% |
| Definium Therapeutics, Inc.NasdaqGS: DFTX | $4.96B | $35.04 | -5.04% |
| Humanwell Healthcare (Group) Co.,Ltd.SHSE: 600079 | $4.69B | CN¥19.23 | +0.31% |
| Hanmi Pharm. Co., Ltd.KOSE: A128940 | $4.54B | ₩480,500.00 | -5.04% |
| Sumitomo Pharma Co., Ltd.TSE: 4506 | $4.51B | ¥1,591.50 | -1.36% |
Figures last refreshed Oct 11, 2026.